Blueprint Medicines Corp (BPMC) Live Share Price, Invest From India

Blueprint Medicines Corp Stock Performance

as on July 18, 2025 at 6:59 am IST

$129.49
Day's Price Range
$129.49
$129.49
52 Week's Low
52 Week's High
$73.04
52-Week Price Range
$129.65
$129.49
43.59%
Downside
0.12%
Upside

Blueprint Medicines Corp share price movements today

Previous Close: $129.28
Open: $129.49
Volume: 422.0
Day's Low - High: $129.49 - $129.49
52 Week Low - High: $73.04 - $129.65

Blueprint Medicines Corp Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Blueprint Medicines Corp Stock Fundamentals & Key Indicators

Check Blueprint Medicines Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Blueprint Medicines Corp stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Blueprint Medicines Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Blueprint Medicines Corp	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Blueprint Medicines Corp Stock

Based on 23 analysts

BUY

73.91%

Buy

17.39%

Hold

8.70%

Sell

Based on 23 analysts, 73.91% of analysts recommend a 'BUY' rating for Blueprint Medicines Corp. Average target price of $130.6

Blueprint Medicines Corp Share Price Target

Get share price movements and forecasts by analysts on Blueprint Medicines Corp.

What analysts predicted

0.85%UPSIDE

Target Price

$130.6

Current Price

$129.49

Analyzed by

23 Analysts

Target

$130.60

Blueprint Medicines Corp target price $130.6, a slight upside of 0.85% compared to current price of $129.49. According to 23 analysts rating.

Blueprint Medicines Corp Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	38	63	57	56	71	96	138	128	146	149
Gross Profit	33	60	55	52	70	88	126	126	138	146
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-158	-129	-132	-133	-110	89	-49	-56	-49	0
Net Profit Margin	-409.06%	-204.72%	-230.66%	-236.38%	-154.14%	92.74%	-36.19%	-43.90%	-34.13%	0.33%

Blueprint Medicines Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	11	27	21	44	66	793	180	204	249	508
Gross Profit	-37	-53	-123	-199	66	793	162	186	236	488
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-52	-72	-148	-236	-328	313	-644	-557	-506	-67
Net Profit Margin	-462.89%	-261.04%	-691.30%	-531.53%	-494.20%	39.54%	-357.67%	-273.24%	-203.30%	-13.19%

Global Institutional Holdings in Blueprint Medicines Corp

Funds	Holdings
BlackRock Inc	10.38%
Vanguard Group Inc	10.27%
T. Rowe Price Associates, Inc.	8.38%
venBio Select Advisor LLC	5.95%
Wellington Management Company LLP	4.75%

See all

About Blueprint Medicines Corp

Blueprint Medicines Corporation is a fully integrated, commercial-stage, global biopharmaceutical company. The Company invents life-changing medicines in two core, strategic areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and PDGFRA Exon 18 mutant GIST in the United States and Europe. It has a pipeline of research and development programs that range from early science to advanced clinical trials in mast cell-mediated diseases, including systemic mastocytosis (SM) and chronic urticaria, breast cancer, and other solid tumors vulnerable to CDK2 inhibition. Its pipeline includes Elenestinib (BLU-263), BLU-808, and BLU-956. It is developing Elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders. It is advancing BLU-808, a potent and selective wild-type KIT inhibitor, for mast cell diseases.

Organisation	Blueprint Medicines Corp
E-voting on shares	Click here to vote

FAQs

What is Blueprint Medicines Corp share price today?

Blueprint Medicines Corp share price today is $129.49 as on July 18, 2025 at 1:29 am IST at the close of the market. Blueprint Medicines Corp share today touched a day high of $129.49 and a low of $129.49.

What is the 52 week high and 52 week low for Blueprint Medicines Corp share?

Blueprint Medicines Corp share touched a 52 week high of $129.65 on July 16, 2025 and a 52 week low of $73.04 on April 9, 2025. Blueprint Medicines Corp stock price today i.e. July 18, 2025 at 1:29 am IST is closed at $129.49,which is 0.12% down from its 52 week high and 77.29% up from its 52 week low.

How to invest in Blueprint Medicines Corp Stock (BPMC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Blueprint Medicines Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Blueprint Medicines Corp Shares that will get you 0.0116 shares as per Blueprint Medicines Corp share price of $129.49 per share as on July 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Blueprint Medicines Corp Stock (BPMC) from India?

Indian investors can start investing in Blueprint Medicines Corp (BPMC) shares with as little as ₹92.68 or $1 (as of April 4, 2026 at 9:23 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹926.80 in Blueprint Medicines Corp stock (as per the Rupee-Dollar exchange rate as on April 4, 2026 at 9:23 am IST). Based on Blueprint Medicines Corp share’s latest price of $129.49 as on July 18, 2025 at 1:29 am IST, you will get 0.0772 shares of Blueprint Medicines Corp. Learn more about fractional shares .